FMP
Virtus LifeSci Biotech Products ETF
BBP
AMEX
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
52.29 USD
-0.1034 (-0.198%)
About
ceo
N/A
sector
Financial Services
industry
Asset Management
website
N/A
exchange
AMEX
Description
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
CIK
0001559109
ISIN
US26923G2021
CUSIP
26923G202
Address
N/A
Phone
NA
Country
US
Employee
N/A
IPO Date
Dec 17, 2014
Summary
ISIN
US26923G2021
Exchange
AMEX
Beta
0.65
Market Cap
19.82M
52-Week
45.0-63.25
Volume Avg.
3.1k
Price
52.29
Country
US
Management Assets
-
Total Holdings
-
NAV
-
NAV Currency
-
Historical Prices
We are unable to load the chart at this time.
Sector Weightings
We are unable to load the chart at this time.
Country Weightings
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BBP News
It looks like there's no news available.
